208 related articles for article (PubMed ID: 491615)
1. The steroid-cancer hypothesis and recent pertinent epidemiological studies.
Hertz R
J Steroid Biochem; 1979 Jul; 11(1B):435-42. PubMed ID: 491615
[TBL] [Abstract][Full Text] [Related]
2. Neoplasia and hormonal contraception.
Huggins GR
Clin Obstet Gynecol; 1981 Sep; 24(3):903-25. PubMed ID: 7026111
[TBL] [Abstract][Full Text] [Related]
3. Cancer risks and the contraceptive pill. What is the evidence after nearly 25 years of use?
Khoo SK
Med J Aust; 1986 Feb; 144(4):185-90. PubMed ID: 3511357
[TBL] [Abstract][Full Text] [Related]
4. Exogenous progestins and breast cancer.
Stanford JL; Thomas DB
Epidemiol Rev; 1993; 15(1):98-107. PubMed ID: 8405216
[TBL] [Abstract][Full Text] [Related]
5. Control of fertility with oral medication.
Diddle AW; Watts GF; Gardner WH; Williamson PJ
West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
[TBL] [Abstract][Full Text] [Related]
6. Effects of long-term estrogen replacement therapy. II. Neoplasia.
Hammond CB; Jelovsek FR; Lee KL; Creasman WT; Parker RT
Am J Obstet Gynecol; 1979 Mar; 133(5):537-47. PubMed ID: 220875
[TBL] [Abstract][Full Text] [Related]
7. Oral contraceptives and neoplasia.
Huggins GR; Giuntoli RL
Fertil Steril; 1979 Jul; 32(1):1-23. PubMed ID: 378712
[TBL] [Abstract][Full Text] [Related]
8. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
[TBL] [Abstract][Full Text] [Related]
9. Progestogens in cardiovascular diseases: an introduction to the epidemiologic data.
Mann JI
Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):752-7. PubMed ID: 7065056
[TBL] [Abstract][Full Text] [Related]
10. Exogenous estrogen and endometrial carcinoma: case-control and incidence study.
McDonald TW; Annegers JF; O'Fallon WM; Dockerty MB; Malkasian GD; Kurland LT
Am J Obstet Gynecol; 1977 Mar; 127(6):572-80. PubMed ID: 190887
[TBL] [Abstract][Full Text] [Related]
11. Effects of the antifertility drug enovid in five strains of mice, with particular regard to carcinogenesis.
Heston WE; Vlahakis G; Desmukes B
J Natl Cancer Inst; 1973 Jul; 51(1):209-24. PubMed ID: 4352748
[TBL] [Abstract][Full Text] [Related]
12. Role of estrogens and progesterone in the etiology and prevention of endometrial cancer: review.
Gambrell RD; Bagnell CA; Greenblatt RB
Am J Obstet Gynecol; 1983 Jul; 146(6):696-707. PubMed ID: 6307050
[TBL] [Abstract][Full Text] [Related]
13. Benign breast tumor and estrogenic hormones: a population-based retrospective study.
Nomura A; Comstock GW
Am J Epidemiol; 1976 May; 103(5):439-44. PubMed ID: 179318
[TBL] [Abstract][Full Text] [Related]
14. Oral contraceptives and gynecologic cancer: an update for the 1990s.
Kaunitz AM
Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 2):1171-6. PubMed ID: 1415442
[TBL] [Abstract][Full Text] [Related]
15. Contraceptive Steroids, age, and the cardiovascular system.
Plunkett ER
Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):747-51. PubMed ID: 7065055
[TBL] [Abstract][Full Text] [Related]
16. The adverse effects of hormonal therapy.
Bush TL
Cardiol Clin; 1986 Feb; 4(1):145-52. PubMed ID: 3518931
[TBL] [Abstract][Full Text] [Related]
17. Exogenous hormones in the aetiology of cancer in women.
Vessey MP
J R Soc Med; 1984 Jul; 77(7):542-9. PubMed ID: 6379176
[TBL] [Abstract][Full Text] [Related]
18. Oral contraceptives: relations to mammary cancer, benign breast lesions, and cervical cancer.
Drill VA
Annu Rev Pharmacol; 1975; 15():367-85. PubMed ID: 1096791
[TBL] [Abstract][Full Text] [Related]
19. Noncontraceptive health benefits of oral steroidal contraceptives.
Mishell DR
Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):809-16. PubMed ID: 7065059
[TBL] [Abstract][Full Text] [Related]
20. Relationship of estrogens and oral contraceptives to endometrial cancer in animals and women.
Drill VA
J Reprod Med; 1980 Jan; 24(1):5-13. PubMed ID: 6987399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
